Clive Kearon
#117,980
Most Influential Person Now
Clive Kearon's AcademicInfluence.com Rankings
Clive Kearonphilosophy Degrees
Philosophy
#5216
World Rank
#7959
Historical Rank
Logic
#2532
World Rank
#3537
Historical Rank
Download Badge
Philosophy
Why Is Clive Kearon Influential?
(Suggest an Edit or Addition)Clive Kearon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) (5208)
- Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. (2012) (3910)
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients (2005) (3512)
- Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (2009) (2402)
- Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (2079)
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (2000) (1517)
- Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. (2003) (1327)
- A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. (1999) (1125)
- Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism (1998) (995)
- Natural History of Venous Thromboembolism (2003) (950)
- Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis (2014) (855)
- A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. (2003) (849)
- Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. (2013) (799)
- Management of anticoagulation before and after elective surgery. (1997) (779)
- Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. (2003) (741)
- Accuracy of clinical assessment of deep-vein thrombosis (1995) (738)
- Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008) (701)
- Aspirin in patients undergoing noncardiac surgery. (2014) (686)
- Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes (2014) (669)
- Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. (1998) (638)
- Noninvasive Diagnosis of Deep Venous Thrombosis (1998) (583)
- Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) (519)
- Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis (2017) (448)
- The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism (1998) (441)
- Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial (2014) (425)
- Definition of post‐thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization (2009) (402)
- Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (367)
- Deep venous thrombosis. (2004) (363)
- Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH (2016) (344)
- Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. (2000) (328)
- Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials (2011) (328)
- Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. (2010) (319)
- Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin (2004) (307)
- Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis (2006) (302)
- The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution (2010) (297)
- Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. (1998) (286)
- Clonidine in patients undergoing noncardiac surgery. (2014) (275)
- Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. (2014) (275)
- Natural history of venous thromboembolism. (2001) (250)
- Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism (1998) (247)
- A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. (1995) (235)
- Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. (2014) (221)
- Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. (2021) (217)
- Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing (2001) (213)
- Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial (2018) (197)
- A randomized trial comparing 5-mg and 10-mg warfarin loading doses. (1999) (191)
- Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis (2005) (185)
- Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry (2010) (171)
- Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis (2014) (169)
- Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. (2013) (169)
- Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study (2017) (168)
- Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular- Weight Heparin for Acute Treatment of Venous Thromboembolism (2006) (166)
- Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. (2019) (160)
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism (2013) (159)
- Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study (2006) (155)
- Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer (2015) (154)
- Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. (2019) (150)
- Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor (2004) (150)
- A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis (2003) (142)
- Clinical Utility of a Rapid Whole-Blood d-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis (1999) (141)
- Practice Guidelines (8th Edition) of Chest Physicians Evidence-Based Clinical Thromboembolic Disease: American College Antithrombotic Therapy for Venous (2008) (139)
- Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial (2020) (138)
- Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis (2019) (136)
- Factors determining pulmonary function in adolescent idiopathic thoracic scoliosis. (1993) (136)
- A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process (1998) (135)
- The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. (1997) (132)
- Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment (2008) (130)
- Duration of venous thromboembolism prophylaxis after surgery. (2003) (128)
- D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. (2015) (127)
- An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism (2006) (127)
- Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. (2008) (123)
- Diagnosis of pulmonary embolism. (2003) (116)
- Management of patients with hereditary hypercoagulable disorders. (2000) (113)
- Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. (2013) (113)
- Long-term management of patients after venous thromboembolism. (2004) (111)
- Emery's elements of medical genetics (2015) (110)
- Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism (2004) (107)
- Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial (2011) (107)
- Early postoperative anticoagulation after mechanical valve replacement: a systematic review. (2006) (106)
- Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial (2019) (106)
- Safety of Withholding Heparin in Pregnant Women With a History of Venous Thromboembolism (2001) (105)
- Use of different d‐dimer levels to exclude venous thromboembolism depending on clinical pretest probability (2004) (104)
- Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism (2007) (103)
- Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting (2010) (102)
- Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. (2006) (101)
- A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II) (2011) (101)
- Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report - Executive Summary. (2021) (97)
- Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial (2013) (97)
- Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin (2007) (97)
- The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. (1996) (95)
- Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. (1999) (93)
- Physical activity in patients with deep venous thrombosis: a systematic review. (2008) (89)
- Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review. (2003) (85)
- Comparison of the Accuracy of Impedance Plethysmography and Compression Ultrasonography in Outpatients with Clinically Suspected Deep Vein Thrombosis (1995) (84)
- Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. (1999) (84)
- Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin (2009) (82)
- Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy (2002) (81)
- Dose–response study of recombinant human soluble thrombomodulin (ART‐123) in the prevention of venous thromboembolism after total hip replacement (2005) (80)
- Development of a research agenda for inferior vena cava filters: proceedings from a multidisciplinary research consensus panel. (2009) (80)
- Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study (2005) (79)
- A comparison of three rapid D‐dimer methods for the diagnosis of venous thromboembolism (2001) (76)
- Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS) (2008) (73)
- Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. (2006) (72)
- Thrombotic disorders: diagnosis and treatment. (2003) (70)
- Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism (2001) (67)
- Starting prophylaxis for venous thromboembolism postoperatively. (1995) (67)
- Epidemiology of venous thromboembolism. (2001) (66)
- A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography (2005) (66)
- Factors that predict thrombosis in relatives of patients with venous thromboembolism. (2014) (64)
- Factors influencing work capacity in adolescent idiopathic thoracic scoliosis. (1993) (64)
- Diagnosis and management of pulmonary embolism (2013) (60)
- Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis. (2011) (59)
- Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism. (2009) (59)
- Noninvasive diagnosis of deep vein thrombosis in postoperative patients. (2001) (59)
- Selective d-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis (2013) (57)
- Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post‐thrombotic syndrome (2015) (51)
- Graduated compression stockings to treat acute leg pain associated with proximal DVT (2014) (49)
- Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden (2006) (49)
- Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. (2018) (49)
- Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia. (1997) (48)
- A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism (2012) (46)
- Effect of warfarin on activated partial thromboplastin time in patients receiving heparin. (1998) (46)
- Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis (2018) (44)
- Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy (2010) (44)
- The diagnosis of pulmonary embolism. (1995) (43)
- Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10 (2010) (42)
- Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel (2016) (42)
- Influence Of Concomitant NSAID Or ASA On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis From RE-Cover and RE-Cover II (2013) (41)
- Differences in clinical presentation of deep vein thrombosis in men and women (2008) (41)
- Venous thromboembolism in association with features of the metabolic syndrome. (2007) (40)
- Laboratory monitoring of low‐molecular‐weight heparin therapy (2004) (40)
- Homocystine-lowering therapy and risks for venous thromboembolism: A randomized trial (2007) (39)
- Meta‐analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery (2014) (37)
- Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta‐analysis (2014) (36)
- Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis (2020) (35)
- Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis. (2004) (34)
- Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up (2012) (32)
- Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism (2012) (31)
- Diagnosis of suspected venous thromboembolism. (2016) (30)
- Utility of ultrasound imaging of the lower extremities in the diagnostic approach in patients with suspected pulmonary embolism (2001) (30)
- Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies (2016) (28)
- Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. (2012) (28)
- Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. (2020) (28)
- Perioperative management of long-term anticoagulation. (1999) (28)
- Perioperative management of patients receiving oral anticoagulants. (2003) (27)
- Long‐term risk of recurrence in patients with a first unprovoked venous thromboembolism managed according to d‐dimer results; A cohort study (2019) (27)
- Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial (2019) (27)
- Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel. (2016) (26)
- Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE). (2018) (26)
- Perioperative Aspirin for Prevention of Venous Thromboembolism: The PeriOperative ISchemia Evaluation-2 Trial and a Pooled Analysis of the Randomized Trials (2016) (25)
- Bleeding events with dabigatran or warfarin in patients with venous thromboembolism (2016) (25)
- Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study (2016) (25)
- Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes (2007) (24)
- Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial (2014) (24)
- Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone. (2013) (24)
- Long-term treatment for venous thromboembolism (2000) (24)
- Perioperative management of oral anticoagulation. (2008) (24)
- Long-term treatment of venous thromboembolism. (2020) (23)
- Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial (2019) (23)
- Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. (2020) (22)
- Hemorrhagic complications of anticoagulant treatment. (2001) (20)
- Duration of therapy for acute venous thromboembolism. (2003) (19)
- Low-dose warfarin in rehabilitating stroke survivors. (2002) (19)
- Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolism (2017) (19)
- Initial Treatment of Venous Thromboembolism (1999) (18)
- Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis (2019) (18)
- Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial (2021) (18)
- Is it useful to also image the asymptomatic leg in patients with suspected deep vein thrombosis? (2015) (18)
- The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy (2011) (17)
- Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand? (2015) (17)
- Duration of Anticoagulation for Venous Thromboembolism (2001) (16)
- Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey. (2006) (16)
- Targeted Gene Sequencing Identifies Variants in the Protein C and Endothelial Protein C Receptor Genes in Patients With Unprovoked Venous Thromboembolism (2013) (15)
- Thromboembolism prevention in ischaemic stroke (2007) (15)
- D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment. (2016) (15)
- Thromboprophylaxis in Non-Surgical Patients:Who, When and How? (1998) (15)
- Factors Influencing the Reported Sensitivity and Specificity of Impedance Plethysmography for Proximal Deep Vein Thrombosis (1994) (14)
- Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance. (2020) (13)
- Clinical pre‐test probability adjusted versus age‐adjusted D‐dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta‐analysis (2019) (13)
- Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism. (2018) (13)
- Clinical Practice Guidelines ( 8 th Edition ) College of Chest Physicians Evidence-Based and Thrombolytic Treatment : American Hemorrhagic Complications of Anticoagulant (2008) (13)
- An approach to dyspnea in cancer patients. (1989) (13)
- Perioperative management of oral anticoagulation. (2006) (13)
- Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolism Kearon C, Ginsberg JS, Julian JA, et al. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of ve (2007) (13)
- Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis (2009) (13)
- A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study. (2007) (13)
- Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated (2011) (12)
- Management of anticoagulation in patients who require invasive procedures. (2003) (12)
- Optimal dose for starting and maintaining low-dose aspirin. (1993) (12)
- Influence of Thrombophilia on the Efficacy of Dabigatran Versus Warfarin for the Extended Treatment of Acute Venous Thromboembolism in RE-MEDY™ (2014) (12)
- Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism (2021) (12)
- Epidemiology of postoperative venous thromboembolism: lessons from an administrative data base (2003) (11)
- Graduated compression stockings to prevent venous thromboembolism in hospital: evidence from patients with acute stroke. (2011) (11)
- Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis. (2000) (11)
- Comparison of the age‐adjusted and clinical probability‐adjusted D‐dimer to exclude pulmonary embolism in the ED (2019) (10)
- Abstract 18594: Efficacy of Dabigatran versus Warfarin in Patients With Acute Venous Thromboembolism and Thrombophilia: A Pooled Analysis of RE-COVER™ and RE-COVER™ II (2014) (10)
- Drug Trials That Have Influenced Our Practice in the Treatment of Venous Thromboembolism (1997) (10)
- Clinical Predictors of Intracranial Bleeding in Older Adults Who Have Fallen: A Cohort Study (2020) (10)
- Predictors of thrombosis in relatives of patients with venous thromboembolism (2010) (10)
- Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multi-center Randomized Trial. (2020) (10)
- Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. (2019) (10)
- A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The S.O.X. Trial (2012) (10)
- Treatment of deep vein thrombosis. (2001) (9)
- Stopping anticoagulant therapy after an unprovoked venous thromboembolism (2008) (9)
- Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism. (2009) (9)
- Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study (2022) (9)
- Long-term anticoagulation for venous thromboembolism: duration of treatment and management of warfarin therapy. (2010) (9)
- Managing challenging patients with venous thromboembolism: a practical, case-based approach. (2017) (9)
- Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis (2021) (8)
- Excluding pulmonary embolism with helical (spiral) computed tomography: Evidence is catching up with enthusiasm. (2003) (8)
- Wells PS, Hirsh J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis (1995) (8)
- Risk of bleeding with vitamin K antagonists compared with low‐molecular‐weight heparin after orthopedic surgery: a rebuttal (2005) (8)
- Duration of treatment (2014) (8)
- Should Patients With Stroke Wear Compression Stockings to Prevent Venous Thromboembolism? (2010) (8)
- Physician choices in pulmonary embolism testing (2021) (8)
- Heparin therapy for deep vein thrombosis: from hospital to home. (2001) (7)
- d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism (2015) (7)
- Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study. (2020) (7)
- Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2) (2018) (7)
- Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis (2017) (7)
- Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism? (2019) (6)
- Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study. (2017) (6)
- Subcutaneous unfractionated heparin for the treatment of venous thromboembolism (2007) (6)
- [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism]. (2008) (5)
- Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis (2014) (5)
- External validation of the SOX‐PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis (2020) (5)
- Evaluation of a VENOus-Return Assist Device (Venowave™) To Treat Severe Post-Thrombotic Syndrome (VENOPTS): A Randomized Controlled Trial. (2006) (5)
- The American College of Chest Physicians score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: More (2019) (5)
- Venous Thromboembolism Recurrence after a First Episode of Provoked Venous Thrombosis Due to a Transient Risk Factor. A Systematic Review of the Literature (2008) (5)
- Statins for venous event reduction in patients with venous thromboembolism: a multicentre randomized controlled pilot trial assessing feasibility. (2021) (4)
- Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta‐analysis (2020) (4)
- Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism (2016) (4)
- Duration of Anticoagulant Therapy After Venous Thromboembolism (2010) (4)
- Exome Sequencing Studies Identify Mutations in STAB2 As a Genetic Risk for Venous Thromboembolic Disease (2017) (4)
- In AF, ABC scores predicted stroke or major bleeding better than CHA2DS2-VASc and HAS-BLED scores, respectively (2019) (4)
- Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring for Acute Treatment of Venous Thromboembolism (VTE): Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH). (2004) (4)
- D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulation Therapy (2015) (4)
- Ruling out pulmonary embolism across different subgroups of patients and healthcare settings: protocol for a systematic review and individual patient data meta-analysis (IPDMA) (2018) (3)
- Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial (2020) (3)
- Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism (2018) (3)
- Inflammation Markers and The Risk Of Post Thrombotic Syndrome: Results From The Bio-Sox Study (2013) (3)
- Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review (2003) (3)
- Contribution of Respiratory Muscle Oxygen Consumption to Breathing Limitation and Cyspnea (1997) (3)
- Obesity, cigarette smoking and hypertension were associated with increased risk of pulmonary embolism in women. (1997) (3)
- Performance of two clinical scales to assess quality of life in post-thrombotic syndrome. (2021) (2)
- Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: reply (2018) (2)
- Positive Predictive Value of Progressively Elevated D-Dimer Levels in Patients with a Suspected First Deep Vein Thrombosis. (2012) (2)
- Treating acute pulmonary embolism: outpatient or inpatient or somewhere in between. (2008) (2)
- Pilot trials in thrombosis: Purpose and pitfalls (2018) (2)
- Deep vein thrombosis (2005) (2)
- Evaluation of a venous-return assist device (venowave) to treat post-thrombotic syndrome: a phase II study (2003) (2)
- Post-Hoc Analysis of RE-MEDY™ Demonstrates Significant Real-World Net Clinical Benefit for Dabigatran Versus Warfarin in Prevention of Secondary Venous Thromboembolism (2014) (2)
- Preoperative risk assessment for bleeding and thromboembolism (2009) (2)
- A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D‐dimer (2021) (2)
- P136: Evaluating the use of the YEARS clinical decision rule for diagnosing pulmonary embolism in the Emergency Department (2018) (2)
- PL03: Prevalence and clinical predictors of intracranial hemorrhage in seniors who have fallen (2019) (2)
- Inter-observer reliability of the HERDOO2 clinical decision rule. (2016) (2)
- LO55: Comparison of the age-adjusted D-dimer, clinical probability-adjusted D-dimer, and Wells rule with D-dimer for diagnosing deep vein thrombosis in the emergency department. (2020) (2)
- Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism (2022) (2)
- Targeted Gene Sequencing to Identify Polymorphisms in the Protein C and EPCR Genes in Patients with Unprovoked Venous Thromboembolism. (2009) (2)
- Diagnosis of Pulmonary Embolism with d-Dimer Testing. Reply. (2020) (2)
- [Optimal duration of anticoagulant treatment of venous thromboembolism]. (2000) (1)
- Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis (2021) (1)
- Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). (2022) (1)
- Pharmacomechanical Therapy for Deep-Vein Thrombosis. (2018) (1)
- Hemorrhagic complications of anticoagulant treatment. (1998) (1)
- Influence of Warfarin on Symptoms of Fatigue: Findings of a Randomized Trial (2005) (1)
- Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial (2013) (1)
- A Randomized, Controlled Two-Center Pilot Trial of a 6-Month Exercise Training Program to Treat the Post-Thrombotic Syndrome: The EXPO Pilot Trial. (2009) (1)
- Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis (2021) (1)
- Long term and short term oral anticoagulation treatments were equivalent for venous thromboembolism (2002) (1)
- Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis (2022) (1)
- The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial (2013) (1)
- Which older emergency patients are at risk of intracranial bleeding after a fall? A protocol to derive a clinical decision rule for the emergency department (2021) (1)
- Inflammation Markers and Their Trajectories after Deep Vein Thrombosis in relation to Risk of Postthrombotic Syndrome INFLAMMATION BIOMARKERS IN PTS (2014) (1)
- Tranexamic acid and rosuvastatin in patients at risk of cardiovascular events after noncardiac surgery: a pilot of the POISE-3 randomized controlled trial (2020) (1)
- P104: Evaluating the use of the pulmonary embolism rule-out criteria in the emergency department (2018) (1)
- Incidence of Recurrent Venous Thromboembolism According to Duration of Vitamin K Antagonists: Results of a Meta-Analysis on Individual Data. (2004) (1)
- Magnetic resonance direct thrombus imaging was accurate in suspected deep venous thrombosis (2002) (1)
- Clarification of Once-Daily Low-Molecular-Weight Heparin Dosing in Pulmonary Embolism: Response (2012) (1)
- 3 months and 1 year of oral anticoagulant therapy were equivalent for idiopathic proximal deep venous thrombosis. (2002) (0)
- Long‐Term Anticoagulation in Venous Thromboembolism (2009) (0)
- TITLE : Optimizing The D-Dimer Threshold Used To Exclude Venous Thromboembolism AUTHOR : (2014) (0)
- A Randomized, Controlled Trial of Varying D-Dimer Cutpoints According to Clinical Pretest Probability Compared with a Uniform D-Dimer Cutpoint for Diagnosis of Deep Vein Thrombosis (2010) (0)
- Transesophageal Echocardiography: Useful Tool or Expensive Toy? (1998) (0)
- Subcutaneous heparin plus pneumatic compression stockings prevented pulmonary embolism after cardiac surgery (1996) (0)
- Practice Guidelines Chest Physicians Evidence-Based Clinical Thrombosis, 9th ed: American College of Antithrombotic Therapy and Prevention of Antithrombotic Therapy for VTE Disease : (2012) (0)
- Intermittent pneumatic compression reduced deep venous thrombosis after stroke (2013) (0)
- Negative D-dimer Not Sufficient to Stop Anticoagulation in Men (2019) (0)
- Anticoagulation is the corner stone of therapy for venous thromboembolism. The optimal duration of this therapy depends on the balance between the risk of recurrent throm- (0)
- A normal alveolar dead space fraction plus d-dimer assay ruled out suspected pulmonary embolism in the emergency department (2001) (0)
- TRANSESOPHAGEAL ECHOCARDIOGRAPHY : USEFUL TOOL OR EXPENSIVE TOY?. AUTHORS'REPLY (1998) (0)
- COMMENT Catheter-Directed Thrombolysis for Pulmonary Embolism Where Do We Stand ? * (2016) (0)
- Deep Vein Thrombosis Diagnosis with D-Dimer Adjusted to Clinical Probability (2020) (0)
- Moderate Renal Impairment and Risk of Bleeding With Anticoagulation (2017) (0)
- Clinical Assessment and D-dimer Testing in Deep Venous Thrombosis (2002) (0)
- “Four weddings and …” (2019) (0)
- OC2. Abstract Title: Comparison of Two Clinical Scales to Assess the Post-Thrombotic Syndrome: Secondary Analysis of a Multicenter Randomized Trial of Pharmacomechanical Catheter-Directed Thrombolysis for Deep Vein Thrombosis (2019) (0)
- Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease. (1998) (0)
- Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease (2016) (0)
- THROMBOSIS AND HEMOSTASIS Factors that predict thrombosis in relatives of patients with venous thromboembolism (2014) (0)
- Chapter 11. Venous Thromboembolism (2007) (0)
- A normal alveolar dead-space fraction plus D-dimer assay ruled out suspected pulmonary embolism in the emergency department (2001) (0)
- Other Uses of LMWHs – Miscellaneous (1998) (0)
- Should Patients With Stroke Wear Compression Stockings (2011) (0)
- Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study Designer D-Dimer Deep vein thrombosis (4D) Study (2022) (0)
- P115: Improving the diagnosis of pulmonary embolism in the emergency department (2020) (0)
- Comparison of Two Clinical Scales to Assess the Post-thrombotic Syndrome: Secondary Analysis of a Multicenter Randomized Trial of Pharmacomechanical Catheter-Directed Thrombolysis for Deep Venous Thrombosis (2020) (0)
- Long-term and short-term oral anticoagulation therapies were equivalent for venous thromboembolism. (2002) (0)
- Role of Gender in the Clinical Presentation of a First Deep Venous Thrombosis (DVT) in Outpatients. (2006) (0)
- Abstract (2003) (0)
- [Preoperative evaluation of bleeding and thromboembolism risk]. (2010) (0)
- Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: reply (2016) (0)
- Clinical assessment and o-dimer testing in deep venous thrombosis. Authors' reply (2002) (0)
- P219 The use of oral modafinil in chronic obstructive pulmonary disease patients with chronic hypercapnic respiratory failure (2017) (0)
- EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY (2007) (0)
- 3 months and 1 year of oral anticoagulant treatment were equivalent for idiopathic proximal deep venous thrombosis (2002) (0)
- Risk Factors and Coagulation Disorders – LMWH Pharmacokinetics and Pharmacodynamics (1998) (0)
- Performance and Head-to-Head Comparison of Three Clinical Models to Predict Occurrence of Postthrombotic Syndrome: A Validation Study (2022) (0)
- LO81: Optimizing the use of CT scanning for pulmonary embolism in the emergency department (2017) (0)
- Are Asymptomatic DVTs Relevant?: Response (2013) (0)
- Thromboprophylaxis in Pregnancy, Orthopaedic Surgery Patients and in Long-Term Strategies (1998) (0)
- Current Monograph in Four Parts (2003) (0)
- "'Issues in Symptom Control" Part 5 An Approach to Dyspnea in Cancer Patients (1989) (0)
- External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. (2022) (0)
- Preface (2003) (0)
- Author Index / Subject Index, Vol. 25, 1995 (1995) (0)
- Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in DVT Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial (2020) (0)
- THROMBOSIS AND HEMOSTASIS Antiphospholipid antibodies and the risk of recurrence after a fi rst episode of venous thromboembolism : a systematic review (2013) (0)
- Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial (2003) (0)
- Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0. (2005) (0)
- Chapter 61. Venous Thromboembolic Disease (2007) (0)
- Effect of patient's sex on risk of recurrent venous thromboembolism : a meta-analysis. Commentary (2007) (0)
- P113: Comparison of age-adjusted and clinical probability-adjusted D-dimer for diagnosing pulmonary embolism (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Clive Kearon?
Clive Kearon is affiliated with the following schools:
